Vascular Occlusion After Dermal Filler Injection: Early Recognition, Prevention, and Management — An Updated Narrative Review

Background: Dermal fillers are widely used in aesthetic medicine for facial rejuvenation, contour restoration, and soft-tissue augmentation. Although generally safe when properly administered, vascular occlusion is one of the most severe filler-related complications because delayed recognition may result in tissue necrosis, scarring, or vision-threatening events. Methods: A narrative literature review was conducted using PubMed and supplementary manual searches, focusing primarily on articles published between January 2018 and April 2026. Search terms included “dermal fillers,” “hyaluronic acid fillers,” “vascular occlusion,” “filler-induced ischemia,” “hyaluronidase,” “ultrasound,” “vision loss,” and “filler complications.” Relevant systematic reviews, clinical guidelines, consensus statements, ophthalmology reports, original studies, and clinically relevant case reports were included. Results: Filler-induced vascular occlusion may occur through inadvertent intravascular injection, retrograde embolization, anterograde propagation, or extrinsic vascular compression. High-risk regions include the glabella, nasal dorsum, nasolabial fold, periorbital region, forehead, temple, and lips. Early findings include sudden blanching, livedo reticularis, delayed capillary refill, severe disproportionate pain, and progressive discoloration. Management should begin immediately based on clinical suspicion and includes cessation of injection, high-dose pulsed hyaluronidase for hyaluronic acid fillers, supportive measures, close monitoring, and urgent ophthalmologic evaluation when visual symptoms occur. High-frequency ultrasound may improve diagnostic precision and guide targeted hyaluronidase administration when available. Conclusions: Dermal filler-induced vascular occlusion is an uncommon but potentially devastating complication requiring rapid recognition and immediate treatment. Prevention depends on anatomical knowledge, careful technique, appropriate product selection, and procedural preparedness. A structured management approach may help reduce treatment delays, standardize care, and improve clinical outcomes.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-06-29
DOI
https://doi.org/10.5281/zenodo.21022850
Primary Topic
Facial Rejuvenation and Surgery Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vascular Occlusion After Dermal Filler Injection: Early Recognition, Prevention, and Management — An Updated Narrative Review

Marisela Silva Garcia, Cristian Sandoval Cervantes
Zenodo (CERN European Organization for Nuclear Research)
Facial Rejuvenation and Surgery Techniques
article

Vascular Occlusion After Dermal Filler Injection: Early Recognition, Prevention, and Management — An Updated Narrative Review

Marisela Silva Garcia, Cristian Sandoval Cervantes
article en

Abstract

Background: Dermal fillers are widely used in aesthetic medicine for facial rejuvenation, contour restoration, and soft-tissue augmentation. Although generally safe when properly administered, vascular occlusion is one of the most severe filler-related complications because delayed recognition may result in tissue necrosis, scarring, or vision-threatening events. Methods: A narrative literature review was conducted using PubMed and supplementary manual searches, focusing primarily on articles published between January 2018 and April 2026. Search terms included “dermal fillers,” “hyaluronic acid fillers,” “vascular occlusion,” “filler-induced ischemia,” “hyaluronidase,” “ultrasound,” “vision loss,” and “filler complications.” Relevant systematic reviews, clinical guidelines, consensus statements, ophthalmology reports, original studies, and clinically relevant case reports were included. Results: Filler-induced vascular occlusion may occur through inadvertent intravascular injection, retrograde embolization, anterograde propagation, or extrinsic vascular compression. High-risk regions include the glabella, nasal dorsum, nasolabial fold, periorbital region, forehead, temple, and lips. Early findings include sudden blanching, livedo reticularis, delayed capillary refill, severe disproportionate pain, and progressive discoloration. Management should begin immediately based on clinical suspicion and includes cessation of injection, high-dose pulsed hyaluronidase for hyaluronic acid fillers, supportive measures, close monitoring, and urgent ophthalmologic evaluation when visual symptoms occur. High-frequency ultrasound may improve diagnostic precision and guide targeted hyaluronidase administration when available. Conclusions: Dermal filler-induced vascular occlusion is an uncommon but potentially devastating complication requiring rapid recognition and immediate treatment. Prevention depends on anatomical knowledge, careful technique, appropriate product selection, and procedural preparedness. A structured management approach may help reduce treatment delays, standardize care, and improve clinical outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Universidad Nacional Autónoma de México (MX)
Openalex Percentile: Top 7%
Facial Rejuvenation and Surgery Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.